Publication | Closed Access

Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression

Breast OncologyMedicinePharmacologyBreast CancerSurvivin ExpressionAnti-cancer AgentCancer TreatmentCancer BiologyCell BiologyGambogic AcidTumor Biology